Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Common-Size Balance Sheet: Assets

Paying user area

Try for free

Abiomed Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Abiomed Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Cash and cash equivalents
Short-term marketable securities
Accounts receivable, net
Inventories, net
Prepaid expenses and other current assets
Current assets
Long-term marketable securities
Property and equipment, net
Goodwill
Other intangibles, net
Deferred tax assets
Investment in Shockwave Medical
Other investments
Operating lease right-of-use assets
Cross-currency swap
Other intangible assets and other assets
Other assets
Long-term assets
Total assets

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Cash and Cash Equivalents
Showed an initial decline from 7.09% in 2017 to 5.46% in 2018, followed by a significant increase reaching a peak of 15.81% in 2020. This level was largely maintained in 2021 at 15.57% before dropping to 7.94% in 2022. The trend indicates fluctuating liquidity with a peak in 2020 and a reduction thereafter.
Short-term Marketable Securities
Displayed variability with an increase from 34.68% in 2017 to 40.6% in 2018, a decline to 20.62% in 2020, and then a rise again to 37.4% by 2022. This suggests active management of short-term investments with shifts in allocation over the periods.
Accounts Receivable, Net
Gradually decreased from 9.82% in 2017 to 5.41% in 2022, indicating either improved collection efficiency or relatively lower sales on credit terms over time.
Inventories, Net
Maintained a relatively stable range, peaking at 7.68% in 2019, before declining to around 5.62% in 2022. The slight downward trend post-2019 could reflect improved inventory management or shifts in business operations.
Prepaid Expenses and Other Current Assets
Exhibited a modest but consistent increase from 1.46% in 2017 to 1.99% in 2022, indicating a slight growth in prepaid or other current assets over the years.
Current Assets
Fluctuated notably, increasing from 59.4% in 2017 to a high of 64.23% in 2019, then dropping sharply to around 52.27-52.73% in 2020 and 2021, followed by a rebound to 58.35% in 2022. This reflects changing asset composition between current and long-term assets.
Long-term Marketable Securities
Declined from 8.57% in 2017 to 2.06% in 2019, then sharply increased to around 17% in 2020 and 2021, and slightly decreased to 13.15% in 2022. This indicates significant changes in investment strategy regarding long-term securities, particularly from 2019 to 2021.
Property and Equipment, Net
Steadily declined from 15.95% in 2017 to 12.1% in 2022, suggesting either depreciation exceeding new investments or divestment of physical assets.
Goodwill
Decreased from 5.64% in 2017 to 2.63% in 2020, followed by an increase to 5.26% in 2021 and a slight decrease to 4.59% in 2022. This pattern may indicate acquisitions or impairments influencing goodwill values in recent years.
Other Intangibles, Net
Declined from 2.63% in 2017 to 1.23% in 2020, then increased to 2.82% in 2021 before decreasing slightly to 2.36% in 2022. This reflects some fluctuations in intangible asset composition or valuation.
Deferred Tax Assets
Reduced substantially from 6.31% in 2017 to 0.63% in 2022, indicating a significant decline in deferred tax assets over the period, possibly due to tax position changes or utilization of deferred tax credits.
Investment in Shockwave Medical
First appeared at 5.33% in 2019, then declined to 2.59% in 2021, before a modest increase to 3.68% in 2022. This signifies the initiation and subsequent partial reduction and recovery of this investment component.
Other Investments
Commenced reporting at 2.33% in 2019 and showed a gradual increase reaching 4.2% in 2022, reflecting growing exposure to other investment assets.
Operating Lease Right-of-Use Assets
Recorded starting 2020 at 0.97%, sharply declining in 2021 to 0.41%, and slightly rising to 0.57% in 2022. This indicates the recognition of leasing assets with some fluctuation in recent years.
Cross-currency Swap
Reported only in 2020 at 0.31%, absent in other periods, suggesting a temporary derivative asset during that year.
Other Intangible Assets and Other Assets
Declined from 1.51% in 2017 to 0.37% in 2022, indicating a substantial reduction in miscellaneous intangible and other asset categories over time.
Other Assets
Increased markedly from 1.51% in 2017 to 8.81% in 2022, with a peak of 9.67% in 2020, signaling growing non-classified long-term asset holdings or reclassifications.
Long-term Assets
Decreased overall from 40.6% in 2017 to 41.65% in 2022, with a notable rise peaking at 47.73% in 2020 before declining. This suggests shifts between long-term and current asset balances, peaking in 2020.
Total Assets
Remained constant at 100% by definition across all periods, serving as the basis for relative asset proportional analysis.